NCT05764876View on ClinicalTrials.gov

Repurposing Clinically Approved Drugs for Yaws with an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)

PHASE3CompletedINTERVENTIONAL
Enrollment

465

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

June 20, 2024

Study Completion Date

December 1, 2024

Conditions
YawsCutaneous Ulcer
Interventions
DRUG

Linezolid Oral Tablet

Oral tablet of linezolid 10mg/kg every 8 hours for 7 days.

DRUG

Azithromycin Oral Tablet

Oral tablet of azithromycin 30mg/kg maximum 2gr single dose.

Trial Locations (1)

Unknown

National Department of Health, Port Moresby

All Listed Sponsors
collaborator

National Department of Health, Papua New Guinea

UNKNOWN

collaborator

School of Medicine and Health Sciences, University of Papua New Guinea

UNKNOWN

lead

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER